Financial news
The newsroom
Headlines from the Federal Reserve, ECB, Bank of Japan, Bank of England, SEC EDGAR, the White House and the DOJ. Context notes are neutral and information-only, Kresmion publishes no buy or sell recommendations.
Public RSS feeds · refreshed every 30 minutes
- 8-K - TOMI Environmental Solutions, Inc. (0000314227) (Filer)
TOMI Environmental Solutions filed a Form 8-K on June 29, 2026, reporting entry into a material definitive agreement, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
United Therapeutics Corp filed a Form 8-K on June 29, 2026 reporting director and officer departures, elections, compensatory arrangements, matters submitted for shareholder vote, and accompanying financial statements and exhibits.
- 8-K - MediaAlpha, Inc. (0001818383) (Filer)
MediaAlpha, Inc. filed a Form 8-K on June 29, 2026, reporting entry into a material definitive agreement and including its financial statements and related exhibits.
- 8-K - Blackstone Private Equity Strategies Fund L.P. (0001930054) (Filer)
Blackstone Private Equity Strategies Fund L.P. filed a Form 8-K reporting unregistered sales of equity securities and a Regulation FD disclosure.
- 8-K - Blackstone Private Equity Strategies Fund (TE) L.P. (0001953940) (Filer)
Blackstone Private Equity Strategies Fund (TE) L.P. filed an 8-K with the SEC on June 29, 2026, reporting unregistered sales of equity securities and providing a Regulation FD disclosure.
- 8-K - Niagen Bioscience, Inc. (0001386570) (Filer)
Niagen Bioscience, Inc. filed an 8-K with the SEC on June 29 2026, indicating that certain matters were submitted to a vote of its security holders.
- 8-K - Meritage Homes CORP (0000833079) (Filer)
Meritage Homes Corp filed a Form 8-K on June 29, 2026, reporting entry into a material definitive agreement, creation of a direct financial obligation or off-balance-sheet arrangement, and accompanying financial statements and exhibits.
- 8-K - GD Culture Group Ltd (0001641398) (Filer)
GD Culture Group Ltd filed a Form 8-K on June 29, 2026, reporting amendments to its articles of incorporation or bylaws and a change in fiscal year, a Regulation FD disclosure, and accompanying financial statements and exhibits.
- 8-K - Midera Food Processing, Inc. (0002088281) (Filer)
Midera Food Processing, Inc. filed an 8-K on June 29, 2026 reporting entry into a material definitive agreement, the creation of a direct financial obligation/off-balance-sheet arrangement, other events, and accompanying financial statements and exhibits.
- 8-K - Blackstone Infrastructure Strategies (TE) L.P. (0002050229) (Filer)
Blackstone Infrastructure Strategies (TE) L.P. filed a Form 8-K reporting unregistered sales of equity securities and providing a Regulation FD disclosure.
- 8-K - Blackstone Infrastructure Strategies L.P. (0002030772) (Filer)
Blackstone Infrastructure Strategies L.P. filed an 8-K on June 29, 2026, reporting unregistered sales of equity securities and including a Regulation FD disclosure.
- 8-K/A - BeyondSpring Inc. (0001677940) (Filer)
BeyondSpring Inc. filed a Form 8-K amendment on June 29, 2026, reporting director and officer departures, elections, appointments, compensatory arrangements, and including financial statements and related exhibits.
- 8-K - PennantPark Private Income Fund (0002089126) (Filer)
PennantPark Private Income Fund filed a Form 8-K on June 29, 2026, reporting entry into a material definitive agreement and providing its financial statements and related exhibits.
- 8-K - CDT Equity Inc. (0001896212) (Filer)
CDT Equity Inc. filed a Form 8-K on June 29 2026, disclosing a change in its certifying public accountant and providing its financial statements and accompanying exhibits.
- 8-K - Cantor Equity Partners II, Inc. (0002034269) (Filer)
Cantor Equity Partners II, Inc. filed a Form 8-K on June 29, 2026, indicating that certain matters were submitted to a vote of its security holders.
- 8-K - Orion S.A. (0001609804) (Filer)
Orion S.A. filed a Form 8-K on June 29, 2026, reporting that it has submitted certain matters to a vote of its security holders, as required under Item 5.07 of the filing.
- 8-K - Schrodinger, Inc. (0001490978) (Filer)
Schrodinger, Inc. filed a Form 8-K with the SEC on June 29 2026, providing a Regulation FD disclosure under Item 7.01.
- 8-K - UiPath, Inc. (0001734722) (Filer)
UiPath, Inc. filed a Form 8-K on June 29, 2026 (Accession No. 0001734722-26-000043) reporting that it has submitted certain matters to be voted on by its security holders, as required under Item 5.07.
- 8-K - COGENT COMMUNICATIONS HOLDINGS, INC. (0001158324) (Filer)
Cogent Communications Holdings, Inc. filed a Form 8-K on June 29, 2026, including a Regulation FD disclosure and accompanying financial statements and exhibits.
- 8-K - DBV Technologies S.A. (0001613780) (Filer)
DBV Technologies S.A. filed a Form 8-K with the SEC on June 29, 2026, reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits).
- 8-K - HERTZ CORP (0000047129) (Filer)
Hertz Corp filed a Form 8-K on June 29, 2026, disclosing a material definitive agreement, a direct financial obligation/off-balance sheet arrangement, unregistered equity sales, other events, and accompanying financial statements and exhibits.
- 8-K - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Filer)
Hertz Global Holdings filed an 8-K reporting entry into a material definitive agreement, creation of a direct financial obligation/off-balance-sheet arrangement, unregistered equity sales, other events, and accompanying financial statements and exhibits.
- 8-K - Pathfinder Bancorp, Inc. (0001609065) (Filer)
Pathfinder Bancorp, Inc. filed a Form 8-K on June 29 2026, including Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits.
- 8-K - Gain Therapeutics, Inc. (0001819411) (Filer)
Gain Therapeutics, Inc. submitted a Form 8-K filing under Item 8.01 (Other Events) to the SEC on June 29, 2026, accession number 0001104659-26-078848, comprising a 194 KB document.
- 8-K - Black Diamond Therapeutics, Inc. (0001701541) (Filer)
Black Diamond Therapeutics, Inc. filed a Form 8-K on June 29, 2026 indicating that certain matters have been submitted to a vote of its security holders, as required by Item 5.07 of the filing.
- 8-K - Tarsus Pharmaceuticals, Inc. (0001819790) (Filer)
Tarsus Pharmaceuticals, Inc. filed a Form 8-K on June 29 2026, reporting that certain matters have been submitted to its security holders for a vote, as disclosed in Item 5.07 of the filing.
- 8-K - IMMUNIC, INC. (0001280776) (Filer)
Immune, Inc. filed a Form 8-K on June 29, 2026 reporting director and officer departures, elections, compensatory arrangements, shareholder voting matters, and accompanying financial statements and exhibits.
- 8-K - Alpex Acquisition Corp (0002125551) (Filer)
Alpex Acquisition Corp filed a Form 8-K on June 29, 2026, reporting a material definitive agreement, unregistered equity sales, changes to directors and officers, amendments to its charter and bylaws, other events, and accompanying financial statements.
- 8-K - Philip Morris International Inc. (0001413329) (Filer)
Philip Morris International Inc. filed a Form 8-K under Item 8.01 (Other Events) on June 29, 2026, accession number 0001104659-26-078814, comprising a 371 KB document.
- 8-K - Frontdoor, Inc. (0001727263) (Filer)
Frontdoor, Inc. filed a Form 8-K reporting departures and appointments of directors and officers, related compensatory arrangements, a Regulation FD disclosure, and accompanying financial statements and exhibits.